{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:17:29Z","timestamp":1770974249099,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.4158\/ep-2020-0220","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:06:42Z","timestamp":1592946402000},"page":"1131-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["VHL-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report"],"prefix":"10.1016","volume":"26","author":[{"given":"Auryan","family":"Szalat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira","family":"Oleinikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avital","family":"Nahmias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vardiella","family":"Meiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Ben-Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Atlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naama","family":"Lev-Cohain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liat","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Gomori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haggi","family":"Mazeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed","family":"Khalaileh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Pe\u2019er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigal","family":"Shoshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Grozinsky-Glasberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2020-0220_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer."},{"key":"10.4158\/EP-2020-0220_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","article-title":"Lindau\u2019s disease. Review of the literature and study of a large kindred","volume":"36","author":"Melmon","year":"1964","journal-title":"Am J Med."},{"key":"10.4158\/EP-2020-0220_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198901000-00001","article-title":"von Hippel-Lindau disease affecting 43 members of a single kindred","volume":"68","author":"Lamiell","year":"1989","journal-title":"Medicine."},{"key":"10.4158\/EP-2020-0220_bb0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","article-title":"Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus","volume":"337","author":"Neumann","year":"1991","journal-title":"Lancet."},{"key":"10.4158\/EP-2020-0220_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pathol.2.010506.092049","article-title":"Von Hippel-Lindau disease","volume":"2","author":"Kaelin","year":"2007","journal-title":"Annu Rev Pathol."},{"key":"10.4158\/EP-2020-0220_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00218913","article-title":"Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours","volume":"93","author":"Crossey","year":"1994","journal-title":"Hum Genet."},{"key":"10.4158\/EP-2020-0220_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"key":"10.4158\/EP-2020-0220_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxiainducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol."},{"key":"10.4158\/EP-2020-0220_bb0050","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","article-title":"Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling","volume":"296","author":"Min","year":"2002","journal-title":"Science."},{"key":"10.4158\/EP-2020-0220_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.beem.2010.01.002","article-title":"VHL disease","volume":"24","author":"Barontini","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0220_bb0060","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med."},{"key":"10.4158\/EP-2020-0220_bb0065","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.3748\/wjg.v16.i36.4515","article-title":"Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease","volume":"16","author":"Tamura","year":"2010","journal-title":"World J Gastroenterol."},{"key":"10.4158\/EP-2020-0220_bb0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00268-019-05299-y","article-title":"Clinical and biochemical features of pheochromocytoma characteristic of Von Hippel-Lindau syndrome","volume":"44","author":"Li","year":"2020","journal-title":"World J Surg."},{"key":"10.4158\/EP-2020-0220_bb0075","first-page":"147","article-title":"Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene","volume":"81","author":"Gross","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0220_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology."},{"key":"10.4158\/EP-2020-0220_bb0085","first-page":"22","article-title":"Clinical utility gene card for: von Hippel-Lindau (VHL)","author":"Decker","year":"2013","journal-title":"Eur J Hum Genet."},{"key":"10.4158\/EP-2020-0220_bb0090","first-page":"599","article-title":"Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease","volume":"26","author":"Marinozzi","year":"2007","journal-title":"J Exp Clin Cancer Res."},{"key":"10.4158\/EP-2020-0220_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10689-019-00149-1","article-title":"Clear cell chondrosarcoma in Von Hippel-Lindau disease","volume":"19","author":"Dreijerink","year":"2020","journal-title":"Fam Cancer."},{"key":"10.4158\/EP-2020-0220_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4158\/EP-2017-0057","article-title":"Pheochromocytoma: a genetic and diagnostic update","volume":"24","author":"Mercado-Asis","year":"2018","journal-title":"Endocr Pract."},{"key":"10.4158\/EP-2020-0220_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/humu.22448","article-title":"Genetic basis of congenital erythrocytosis: mutation update and online databases","volume":"35","author":"Bento","year":"2014","journal-title":"Hum Mutat."},{"key":"10.4158\/EP-2020-0220_bb0110","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1907362","article-title":"Effects of germline VHL deficiency on growth, metabolism, and mitochondria","volume":"382","author":"Perrotta","year":"2020","journal-title":"N Engl J Med."},{"key":"10.4158\/EP-2020-0220_bb0115","first-page":"4568","article-title":"Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas","volume":"85","author":"Bender","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0220_bb0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet."},{"key":"10.4158\/EP-2020-0220_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.4158\/EP-2020-0220_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP14481.RA","article-title":"Pheochromocytoma and paraganglioma","volume":"21","author":"Pacak","year":"2015","journal-title":"Endocr Pract."},{"key":"10.4158\/EP-2020-0220_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12020-010-9422-5","article-title":"Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center","volume":"39","author":"Szalat","year":"2010","journal-title":"Endocrine."},{"key":"10.4158\/EP-2020-0220_bb0140","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1067\/msy.1998.91823","article-title":"Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations","volume":"124","author":"Libutti","year":"1998","journal-title":"Surgery."},{"key":"10.4158\/EP-2020-0220_bb0145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","article-title":"Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs)","volume":"142","author":"Blansfield","year":"2007","journal-title":"Surgery."},{"key":"10.4158\/EP-2020-0220_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/jamaoncol.2017.3428","article-title":"Association of VHL genotype with pancreatic neuroendocrine tumor phenotype in patients with von Hippel-Lindau disease","volume":"4","author":"Tirosh","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.4158\/EP-2020-0220_bb0155","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/SLA.0000000000000856","article-title":"Long-term prognosis of resected pancreatic neuroendocrine tumors in von Hippel-Lindau disease is favorable and not influenced by small tumors left in place","volume":"262","author":"de Mestier","year":"2014","journal-title":"Ann Surg."},{"key":"10.4158\/EP-2020-0220_bb0160","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1210\/jc.2017-02434","article-title":"In silico VHL gene mutation analysis and prognosis of pancreatic neuroendocrine tumors in von Hippel-Lindau disease","volume":"103","author":"Tirosh","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0220_bb0165","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O\u2019Brien","year":"2010","journal-title":"Hum Mutat."},{"key":"10.4158\/EP-2020-0220_bb0170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/humu.20948","article-title":"Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients","volume":"30","author":"Franke","year":"2009","journal-title":"Hum Mutat."},{"key":"10.4158\/EP-2020-0220_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat."},{"key":"10.4158\/EP-2020-0220_bb0180","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/gim.2017.261","article-title":"Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-alpha binding site in VHL protein","volume":"20","author":"Liu","year":"2018","journal-title":"Genet Med."},{"key":"10.4158\/EP-2020-0220_bb0185","doi-asserted-by":"crossref","first-page":"e1006478","DOI":"10.1371\/journal.pcbi.1006478","article-title":"Genotypephenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and inter-actors","volume":"15","author":"Minervini","year":"2019","journal-title":"PLoS Comput Biol."},{"key":"10.4158\/EP-2020-0220_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/ERC-13-0308","article-title":"Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations","volume":"21","author":"Kruizinga","year":"2013","journal-title":"Endocr Relat Cancer."},{"key":"10.4158\/EP-2020-0220_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0300-2977(01)00165-6","article-title":"Clinical management of Von Hippel-Lindau (VHL) disease","volume":"59","author":"Hes","year":"2001","journal-title":"Neth J Med."},{"key":"10.4158\/EP-2020-0220_bb0200","first-page":"B","article-title":"Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition","volume":"60","author":"Binderup","year":"2013","journal-title":"Dan Med J."},{"key":"10.4158\/EP-2020-0220_bb0205","series-title":"VHLA Suggested Active Surveillance Guidelines","author":"VHL Alliance.","year":"2017"},{"key":"10.4158\/EP-2020-0220_bb0210","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel-Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:46Z","timestamp":1761516586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20482187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1530891X20482187"],"URL":"https:\/\/doi.org\/10.4158\/ep-2020-0220","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VHL-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2020-0220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}